Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

NCT05845307 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped 0 participants

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Control Group
DRUG: TTI-101

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]